However, we also observed that FOXM1 inhibition induced the differentiation of primary human leukemia cells, as evidenced by presence of significant number of differentiated myeloid cells in BM from FOXM1-specific peptide-treated xenografted mice as compared to PBS-treated mice (Fig. 9k). This evidence concerns the gene FOXM1 and leukemia.